Divi’s Laboratories – Wave (C) Decline Targeting Lower ZonesWave Count
Divi’s Laboratories topped at ₹7,071.50, completing a 5-wave impulse.
From there, price declined in five clear waves into Wave (A) at ₹5,856.50.
The subsequent bounce unfolded as an abc zigzag, peaking at ₹6,314.50 — aligning perfectly with the 0.382 Fibonacci retracement of the 7,071.50
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
86.85 INR
21.91 B INR
93.58 B INR
126.63 M
About Divi's Laboratories Limited
Sector
Industry
CEO
Satchandra Kiran Divi
Website
Headquarters
Hyderabad
Founded
1990
ISIN
INE361B01024
FIGI
BBG000DJVYM0
Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates, and nutraceutical. It also provides manufacturing of generic APIs, nutraceutical ingredients, and custom synthesis for big pharma. The company was founded by Murali Krishna Prasad Divi on October 12, 1990 and is headquartered in Hyderabad, India.
Related stocks
DIVISLAB - Falling Wedge pattern Breakout --> BullishEntry @6248
✅ Overall View
Current Price: ₹6248.50
RSI (Relative Strength Index): 47.62 → This indicates a neutral zone (neither overbought nor oversold).
✅ Support and Resistance Levels
Supports:
S1: ₹6010
S2: ₹6020.35
S3: ₹6162
Price is above all supports, which is positive.
Resistances:
Understanding Volume ImbalancesUnderstanding Volume Imbalances – The Market’s Unfinished Business
A Volume Imbalance occurs when price moves very quickly upward or downward, leaving behind price zones where little or no trading has taken place – often called No Trade Zones. These imbalances can be spotted on the daily timeframe
DIVISLAB: Flag & Pole Breakout Setup Targets New ATHsNSE: DIVISLAB | Pharmaceuticals | Large Cap | Updated: June 17, 2025
📊 Technical Structure
Pole Formation: Rally from 4,955 → 6,862 (1,907 points) on high volume
Flag Consolidation: Tight range between 6,490 (support) and 6,800 (resistance)
Key Breakout Trigger: Daily close above 6,862 (ATH)
Pat
[DIVISLAB] - Potential pullback entry at the [RTS + DZ]
STOCK TREND - BULLISH
MULTI TF ANALYSIS
=================
MONTHLY - Rounding Bottom + ATH breakout with good Volume
WEEKLY - Box Consolidation near ATH
DAILY - Box Consolidation + Resistance turned Support(RTS) level breakout
TECHNICAL ANALYSIS
===================
Stock Price is trading above
PCR ( Put Call Ratio) Trading StrategyThe Put Call Ratio (PCR) is a market sentiment indicator calculated by dividing the total volume of put options by the total volume of call options. It's used to gauge whether traders are predominantly betting on a market decline (puts) or rise (calls). A high PCR suggests bearish sentiment, while a
DIVISLAB -Inverted Head and Shoulders -DailyThanks for the clarification! Yes — the chart **does** resemble an **Inverted Head and Shoulders** pattern (a bullish reversal pattern), especially visible in the price structure before the breakout above ₹6,278.
---
### 🟢 **Inverted Head and Shoulders – Analysis (Divi's Lab)**
#### **Pattern Str
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DIVISLAB is 6,009.00 INR — it has decreased by −2.03% in the past 24 hours. Watch Divi's Laboratories Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Divi's Laboratories Limited stocks are traded under the ticker DIVISLAB.
DIVISLAB stock has fallen by −2.01% compared to the previous week, the month change is a −6.26% fall, over the last year Divi's Laboratories Limited has showed a 17.82% increase.
We've gathered analysts' opinions on Divi's Laboratories Limited future price: according to them, DIVISLAB price has a max estimate of 7,700.00 INR and a min estimate of 4,098.00 INR. Watch DIVISLAB chart and read a more detailed Divi's Laboratories Limited stock forecast: see what analysts think of Divi's Laboratories Limited and suggest that you do with its stocks.
DIVISLAB reached its all-time high on Jul 8, 2025 with the price of 7,071.50 INR, and its all-time low was 7.75 INR and was reached on Mar 12, 2003. View more price dynamics on DIVISLAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DIVISLAB stock is 2.92% volatile and has beta coefficient of 0.74. Track Divi's Laboratories Limited stock price on the chart and check out the list of the most volatile stocks — is Divi's Laboratories Limited there?
Today Divi's Laboratories Limited has the market capitalization of 1.60 T, it has decreased by −2.06% over the last week.
Yes, you can track Divi's Laboratories Limited financials in yearly and quarterly reports right on TradingView.
Divi's Laboratories Limited is going to release the next earnings report on Nov 10, 2025. Keep track of upcoming events with our Earnings Calendar.
DIVISLAB earnings for the last quarter are 20.50 INR per share, whereas the estimation was 22.29 INR resulting in a −8.02% surprise. The estimated earnings for the next quarter are 24.75 INR per share. See more details about Divi's Laboratories Limited earnings.
Divi's Laboratories Limited revenue for the last quarter amounts to 24.10 B INR, despite the estimated figure of 24.69 B INR. In the next quarter, revenue is expected to reach 26.53 B INR.
DIVISLAB net income for the last quarter is 5.45 B INR, while the quarter before that showed 6.62 B INR of net income which accounts for −17.67% change. Track more Divi's Laboratories Limited financial stats to get the full picture.
Yes, DIVISLAB dividends are paid annually. The last dividend per share was 30.00 INR. As of today, Dividend Yield (TTM)% is 0.50%. Tracking Divi's Laboratories Limited dividends might help you take more informed decisions.
Divi's Laboratories Limited dividend yield was 0.52% in 2024, and payout ratio reached 36.35%. The year before the numbers were 0.87% and 49.78% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 6, 2025, the company has 18.3 K employees. See our rating of the largest employees — is Divi's Laboratories Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Divi's Laboratories Limited EBITDA is 30.74 B INR, and current EBITDA margin is 32.49%. See more stats in Divi's Laboratories Limited financial statements.
Like other stocks, DIVISLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Divi's Laboratories Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Divi's Laboratories Limited technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Divi's Laboratories Limited stock shows the buy signal. See more of Divi's Laboratories Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.